Scholars Central

Conference abstractPublished 17 Jun 2019

Pharmacophore modeling, synthesis, scaffold hopping and biological β-hematin inhibition interaction studies as antimalaria compounds: An approach for multitarget anticancer drug design

Authors: Neda Fayyazi

Isfahan Medical University, Iran

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Exploring potent compounds is a critical first step in the multi-target drug discovery. The primary mechanism of heme detoxification in malaria parasites is hematin crystallization and the target of the antimalaria compounds. A series of chloroquine analogues were designed using the repositioning approach to develop new anticancer compounds. The fingerprints of the protein ligand interaction and ADMET descriptors are used to build and asses’ model for structure based drug discovery to develop new scaffold based on chloroquine hybrid β-hematin inhibitors. In the present study, 50 novel potent chloroquine hybrid β-hematin inhibitors with their IC50 values were collected, was applied. The model built by partial least square algorithm showed excellent predictive power with the correlation coefficients for calibration and cross validation of r2 = 0.93 and q2 = 0.72. We developed and validated QSAR model in prediction of a newly synthesized series of 4-aminoquinolin hybrids and evaluated for their biological activity as an external test series. These compounds were evaluated for cytotoxic cell lines and β-hematin inhibition. The target compounds exhibited high β-hematin inhibition activity and were 3-9 times more active than the positive control. Furthermore, all compounds exhibited moderate to high cytotoxic activity. Pharmacophore features from 10 derivatives in model were generated with HIP-HOP algorithm then used for structure based virtual screening in commercial databases; leading to the identification of the compound with the best score from ChEMBL was 2016904, previously reported as VEGFR-2 inhibitor. The 11 compounds selected have performed a multi-parameter analysis for the comparison of compounds regarding their correlation between dual potency, target evaluation and predicted ADMET properties for drug development.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectPharmaceutical Sciences
  • SubjectMathematics & Statistics
  • BylineArticles whose byline prints “Neda Fayyazi”